← FDA Drug Approvals (Drugs@FDA)

TRUQAP

NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2023-11-16

Drug application

FDA Application #
NDA218197
Application type
New Drug Application
Brand name
TRUQAP
Generic name
CAPIVASERTIB
Active ingredients
CAPIVASERTIB
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
ASTRAZENECA
Manufacturer
AstraZeneca Pharmaceuticals LP
First approval
2023-11-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown